Novo Nordisk sues Hims & Hers

Hims & Hers shares surge

Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo's branded medicines through its platform.

· 1d

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

· 22h · on MSN

Novo Nordisk to sell weight-loss drugs through Hims & Hers

· 20h

Novo Nordisk Hims And Hers Deal Reframes Obesity Drug Growth Story

Novo Nordisk, ticker CPSE:NOVO B, has settled its legal dispute with Hims & Hers Health over unauthorized versions of Wegovy and Ozempic.

· 1d

Hims & Hers Stock Surges as Novo Nordisk Deal Ends Legal Dispute

· 1d

Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know

29d

Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss pill Wegovy.

AOL

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of its blockbuster GLP-1 medication semaglutide.

Trending on Bing

Hims & Hers shares surge